Testing gepant migraine treatment for better side effects
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This trial studies how well a “gepant” medicine works for different types of migraine and how tolerable it is. It may help if you have frequent migraines and you can keep a headache diary as the study asks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have migraine diagnosed as: migraine without aura, migraine with aura, or chronic migraine
- You have at least 3 migraine days (or “MMDs”) during the study timeframe
- You can follow the study plan and visit schedule as required
- You have headache records (a headache diary) from the months before joining
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called rimegepant to see if it helps prevent migraines. If you have migraine at least 4 days per month, this might be for you.
This study tests if the drug rimegepant can help prevent migraine attacks in women. It aims to see how well it works in real life in China.
This trial tests whether a medication called rimegepant can prevent migraines when you take it before a known trigger (like exercise or stress). It is for people who get migraines often and can predict when one might happen.
This trial studies whether rimegepant can reduce how often migraine attacks happen in children and teens. It also looks at safety and how well the treatment fits day-to-day life and school activities.
This trial tests two new migraine medicines, rimegepant and zavegepant, given to people in the emergency department to see how well they work for stopping a migraine headache quickly.
This study tests how well a new acute migraine medicine, zavegepant, works and is tolerated in people who are already taking a CGRP-targeting preventive medication. It may help you find an effective treatment when you get a migraine attack.
Hear when a new Migraine trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.